RT Journal Article
SR Electronic
T1 Trends and Patterns of Opioid Epidemic: A Large-Scale Retrospective Study of Hospital Visits with Opioid Poisoning in New York State, 2010-2016
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.01.20185991
DO 10.1101/2020.09.01.20185991
A1 Xin Chen
A1 Wei Hou
A1 Sina Rashidian
A1 Yu Wang
A1 Xia Zhao
A1 Richard N Rosenthal
A1 Mary Saltz
A1 Joel H Saltz
A1 Elinor Randi Schoenfeld
A1 George Stuart Leibowitz
A1 Fusheng Wang
YR 2020
UL http://medrxiv.org/content/early/2020/09/03/2020.09.01.20185991.abstract
AB Introduction To discover trends and patterns of opioid poisoning and the demographic and regional disparities by analyzing large scale patient visits data in New York State (NYS).Methods Demographic, spatial, temporal and correlation analyses were performed for all OP patients extracted from the New York Statewide Planning and Research Cooperative System (SPARCS) from 2010 to 2016, along with Decennial US Census and American Community Survey zip code level data. The study is based on claims data. 58,481 patients with at least one OP diagnosis and a valid NYS zip code address were included. OP patient counts and rates per 100,000 population; patient level factors (gender, age, race and ethnicity, residential zip code); zip code level social demographic factors. Analyses were completed between 2017 and 2019.Results In this study of 58,481 patients with opioid poisoning (OP) in New York State from 2010 to 2016, the OP rate increased by 364.6%, and by 741.5% for the age group > 65 years. There were wide disparities among groups by race and ethnicity on rates and age distributions of OP. Heroin and non-Heroin based OP rates show distinct temporal trends as well as major geospatial variation.Conclusions The findings highlight strong demographic disparity of OP patients, evolving patterns and substantial geospatial variation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported in part by National Science Foundation ACI 1443054 and by NSF IIS 1350885, and Stony Brook University OVPR Seed Grant. The authors disclose no conflicts of interest. The study funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board of Stony Brook University, and the Office of Quality and Patient Safety, Department of Health of New York State.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is from New York Statewide Planning and Research Cooperative System (SPARCS) which is available for research purposes upon request and approval.